Moderna, Inc. Common Stock vs. Tectonic Therapeutic, Inc. Common Stock
MRNA
Moderna, Inc. Common Stock
$154.27 +9.93%
VS TECXTectonic Therapeutic, Inc. Common Stock
$31.22 +4.28%
Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| MRNA | TECX | |
|---|---|---|
| Market Cap | $56.03 billion | $585.31 million |
| Revenue (TTM) | $2.23 billion | — |
| Net Income (TTM) | $-3,151,000,000 | — |
MRNA leads on 1 of 1 size & scale factors.
Valuation
| MRNA | TECX | |
|---|---|---|
| Price / Book | 8.29 | — |
| Price / Sales | 25.15 | — |
MRNA and TECX split the valuation factors evenly.
Profitability
| MRNA | TECX | |
|---|---|---|
| Net Margin | -141.43% | — |
| Return on Equity | -46.61% | — |
MRNA and TECX split the profitability factors evenly.
Risk & Sentiment
| MRNA | TECX | |
|---|---|---|
| Short Interest | 0.01% | 0.09% |
MRNA leads on 1 of 1 risk & sentiment factors.
Dig deeper: MRNA overview, MRNA financials, TECX overview, TECX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.